In their recent well-designed study which enrolled 121 ovarian cancer patients, Tong et al. demonstrated that the expression levels of GSTP1 was lower in the chemotherapy-sensitive group than in the chemotherapy-resistant group of patients. This evidence concerns the gene GSTP1 and ovarian carcinoma.